No connection

Search Results

HQL

BULLISH
$17.56 Live
Abrdn Life Sciences Investors · NYSE
$11.88 52W Range $18.1

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 28, 2026
Market cap
$533.97M
P/E
6.29
ROE
17.6%
Profit margin
4415.7%
Debt/Equity
N/A
Dividend yield
12.76%

AI Analysis

AI-powered fundamental assessment

Confidence
75%
HQL presents as a deep-value opportunity, anchored by a stable Piotroski F-Score of 6/9 and a significant valuation gap, with a current price of $17.56 trading well below its Graham Number ($33.01) and Intrinsic Value ($82.31). While the company exhibits severe operational anomalies—specifically a -69.90% revenue collapse and a deeply negative operating margin—the massive earnings growth and low P/E ratio (6.29) suggest the entity is benefiting from significant investment gains rather than core fee income. The high dividend yield of 12.76% is supported by a sustainable payout ratio, though the bearish technical trend (10/100) suggests a period of consolidation or price correction is underway.

Key Strengths

Extreme undervaluation relative to Graham Number ($33.01) and Intrinsic Value ($82.31)
Very low P/E ratio (6.29) compared to the sector average of 36.83
Strong dividend yield of 12.76% with a manageable payout ratio (65.23%)
Stable financial health as indicated by a Piotroski F-Score of 6/9
Strong long-term price performance (5Y Change: +46.2%)

Key Risks

Severe revenue decline (-69.90% YoY) indicating a collapse in core business growth
Poor operational efficiency with an operating margin of -346.83%
Liquidity risk evidenced by a current ratio of 0.73 (below 1.0)
Highly bearish technical trend (10/100) suggesting negative short-term momentum
Lack of analyst coverage and insider activity provides no external validation
AI Fair Value Estimate
Based on comprehensive analysis
$33.01
+88.0% above current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
73
Strong
Value
95
Future
35
Past
85
Health
60
Dividend
90
AI Verdict
Deep Value / Income Play
Key drivers: Massive discount to intrinsic value, High dividend yield, Operational revenue collapse
Confidence
80%
Value
95/100

Ref P/E 6.29, Graham Number $33.01

Positives
  • P/E of 6.29 is significantly below sector average
  • Price/Book of 1.01 suggests fair asset pricing
  • Trading at ~53% of Graham Number
Watchpoints
No urgent risks highlighted.
Future
35/100

Ref Revenue Growth -69.90%

Positives
  • Strong earnings growth (259.40%)
Watchpoints
  • Catastrophic revenue growth (-69.90%)
  • Bearish technical trend
Past
85/100

Ref 5Y Change +46.2%

Positives
  • Consistent growth over 1Y, 3Y, and 5Y horizons
  • Strong recovery in earnings
Watchpoints
No urgent risks highlighted.
Health
60/100

Ref Piotroski F-Score 6/9, Current Ratio 0.73

Positives
  • Piotroski F-Score of 6/9 indicates stability
Watchpoints
  • Current ratio 0.73 indicates potential liquidity pressure
  • Negative operating margin
Dividend
90/100

Ref Yield 12.76%, Payout 65.23%

Positives
  • Very high yield (12.76%)
  • Payout ratio (65.23%) is within healthy limits
Watchpoints
No urgent risks highlighted.

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$17.56

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for HQL and closest competitors.

Updated 2026-04-27
HQL
Abrdn Life Sciences Investors
Primary
5Y
+46.2%
3Y
+81.4%
1Y
+59.5%
6M
+7.8%
1M
+9.4%
1W
-2.3%
ARO
Arrow Financial Corporation
Peer
5Y
+14.4%
3Y
+38.0%
1Y
+30.5%
6M
+14.0%
1M
-7.1%
1W
-2.9%
BLW
BlackRock Limited Duration Income Trust
Peer
5Y
+34.9%
3Y
+35.5%
1Y
+6.4%
6M
+2.4%
1M
+0.9%
1W
+0.6%
SFS
Southern First Bancshares, Inc.
Peer
5Y
+13.7%
3Y
+96.9%
1Y
+68.4%
6M
+33.2%
1M
+6.2%
1W
-3.7%
BGB
Blackstone Strategic Credit 2027 Term Fund
Peer
5Y
+38.8%
3Y
+43.3%
1Y
+5.0%
6M
-0.5%
1M
+2.1%
1W
-0.1%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
6.29
Forward P/E
N/A
PEG Ratio
N/A
P/B Ratio
1.01
P/S Ratio
275.47
EV/Revenue
268.1
EV/EBITDA
N/A
Market Cap
$533.97M

Profitability

Profit margins and return metrics

Profit Margin 4415.74%
Operating Margin -346.83%
Gross Margin 100.0%
ROE 17.59%
ROA -0.43%

Growth

Revenue and earnings growth rates

Revenue Growth -69.9%
Earnings Growth +259.4%
Q/Q Revenue Growth N/A
Q/Q Earnings Growth +279.1%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
N/A
Current Ratio
0.73
Weak
Quick Ratio
0.71
Poor
Cash/Share
$0.0

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q3 2025

Total Assets
$0.5B
Liabilities
$0.0B
Equity
$0.5B
Debt/Equity
0.00x

Financial Services Sector Comparison

Comparing HQL against 820 companies in the Financial Services sector (141 bullish, 351 neutral, 328 bearish)
P/E Ratio
6.29
This Stock
vs
36.01
Sector Avg
-82.5% (Discount)
Return on Equity (ROE)
17.59%
This Stock
vs
-0.73%
Sector Avg
-2500.2% (Below Avg)
Profit Margin
4415.74%
This Stock
vs
91.62%
Sector Avg
+4719.7% (Superior)
Revenue Growth
-69.9%
This Stock
vs
35.27%
Sector Avg
-298.2% (Slower)
Current Ratio
0.73
This Stock
vs
3.18
Sector Avg
-77.0% (Weaker)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

PITTARD CHRISTIAN ALEXANDER JOHN
Director
Buy
2025-12-16
7,923 shares · $133,755
Insider transactions can signal confidence or concerns about company prospects

Past News Coverage

Recent headlines mentioning HQL from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile